Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders??? Equity

v3.25.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Class A and Class B Common Stock
Common Stock
Beginning balance (in shares) at Jan. 31, 2022               256,481,000
Beginning balance at Jan. 31, 2022 $ 515,849   $ 982,122 $ (23,831) $ (820) $ (441,630)   $ 8
Beginning balance (in shares) at Jan. 31, 2022       14,131,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation - equity classified awards 57,057   57,057          
Exercise of stock options and vesting of RSUs (in shares)               6,014,000
Exercise of stock options and vesting of RSUs 24,740   24,740          
Issuance of common shares upon ESPP purchases (in shares)               1,259,000
Issuance of common shares upon ESPP purchases 10,231   10,230         $ 1
Other comprehensive (loss) income (3,564)       (3,564)      
Other adjustments (in shares)               (13,000)
Net income (loss) (55,742)         (55,742)    
Ending balance (in shares) at Jan. 31, 2023               263,741,000
Ending balance at Jan. 31, 2023 $ 549,332 $ 761 1,074,149 $ (23,831) (4,384) (496,611) $ 761 $ 9
Ending balance ( in shares) at Jan. 31, 2023       14,131,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting standards update, extensible enumeration Accounting Standards Update 2016-13 [Member]              
Stock-based compensation - equity classified awards $ 57,230   57,230          
Exercise of stock options and vesting of RSUs (in shares)               10,948,000
Exercise of stock options and vesting of RSUs 43,333   43,333          
Issuance of common shares upon ESPP purchases (in shares)               976,000
Issuance of common shares upon ESPP purchases 7,437   7,437          
Common stock repurchased, including excise tax (in shares)               (2,400,000)
Common stock repurchased, including excise tax (29,579)         (29,579)    
Other comprehensive (loss) income 548       548      
Other adjustment 0   1         $ (1)
Net income (loss) 51,403         51,403    
Ending balance (in shares) at Jan. 31, 2024               273,265,000
Ending balance at Jan. 31, 2024 $ 679,704   1,182,150 $ (23,831) (3,836) (474,787)   $ 8
Ending balance ( in shares) at Jan. 31, 2024 14,130,784     14,131,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation - equity classified awards $ 61,055   61,055          
Exercise of stock options and vesting of RSUs (in shares)               6,862,000
Exercise of stock options and vesting of RSUs 19,908   19,908          
Issuance of common shares upon ESPP purchases (in shares)               776,000
Issuance of common shares upon ESPP purchases 5,807   5,807          
Common stock repurchased, including excise tax (in shares)               (25,460,000)
Common stock repurchased, including excise tax (272,887)         (272,887)    
Other comprehensive (loss) income (3,133)       (3,133)      
Net income (loss) 121,609         121,609    
Ending balance (in shares) at Jan. 31, 2025               255,443,000
Ending balance at Jan. 31, 2025 $ 612,063   $ 1,268,920 $ (23,831) $ (6,969) $ (626,065)   $ 8
Ending balance ( in shares) at Jan. 31, 2025 14,130,784     14,131,000